Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.

Head & Neck
Emile GogineniMaged Ghaly

Abstract

Patients with head and neck cancer (HNC) who are not candidates for definitive treatment represent an increasing challenge, with limited data to guide management. Conventional local therapies such as surgery and chemoradiation can significantly impact quality of life (QoL). There has been limited data published using stereotactic body radiotherapy (SBRT) as primary treatment in previously unirradiated patients. We hypothesize that SBRT provides high rates of control while limiting toxicity. A total of 66 medically unfit previously unirradiated patients with HNC were treated with SBRT, consisting of 35-40 Gy to gross tumor volume and 30 Gy to clinical target volume in five fractions. Median age was 80 years. Local control (LC) and overall survival (OS) at 1 year were 73% and 64%. Two patients experienced grade 3 toxicity. SBRT shows acceptable outcomes with relatively low toxicity in previously unirradiated patients with HNC who are medically unfit for conventional treatment. SBRT may provide an aggressive local therapy with high rates of LC and OS while maintaining QoL.

References

Apr 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A LusinchiF Eschwege
Mar 15, 1993·International Journal of Radiation Oncology, Biology, Physics·K J ParisF Albrink
Mar 1, 1995·Archives of Otolaryngology--head & Neck Surgery·W M KochD Sidransky
Jun 2, 1998·International Journal of Radiation Oncology, Biology, Physics·M OguchiS Sone
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Margaret KemenyHarvey J Cohen
Nov 2, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·June CorrySandro Porceddu
Sep 7, 2007·Journal of Palliative Medicine·Luis A CarrascosaWilliam J Spanos
Nov 27, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sandro V PorcedduTanya Holt
Apr 1, 2008·Critical Reviews in Oncology/hematology·Jay F PiccirilloEwout W Steyerberg
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitchell MachtayK Kian Ang
Jul 25, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jai Prakash AgarwalKetayun Dinshaw
Mar 31, 2009·International Journal of Radiation Oncology, Biology, Physics·Farzan SiddiquiSamuel Ryu
May 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin D SmithThomas A Buchholz
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Mar 18, 2010·JAMA : the Journal of the American Medical Association·Robert TimmermanHak Choy
Jul 30, 2010·Indian Journal of Palliative Care·Sushmita GhoshalFiruza D Patel
Oct 12, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·K N KancherlaM Sen
Jul 19, 2011·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Koji KawaguchiYoshiki Hamada
Feb 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Bénédicte CometEric F Lartigau
Sep 19, 2012·Seminars in Radiation Oncology·Farzan Siddiqui, Clement K Gwede
May 3, 2013·The Oncologist·Noam A VanderWaldeBhishamjit S Chera
Aug 21, 2013·American Journal of Otolaryngology·Megan E DalyAllen M Chen
Nov 23, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Eric F LartigauAndrew Kramar
Nov 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cindy KenisHans Wildiers
Jan 1, 2012·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Jasenka Gugić, Primož Strojan
Jun 18, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L DecosterM Extermann
Oct 9, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Luluel KhanIan Poon
Mar 30, 2016·International Journal of Radiation Oncology, Biology, Physics·Bernard FortinLouise Lambert
Jun 22, 2016·International Journal of Radiation Oncology, Biology, Physics·Jack PhanSteven J Frank
Sep 16, 2016·Frontiers in Oncology·Petr Szturz, Jan B Vermorken
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Sep 14, 2017·International Journal of Radiation Oncology, Biology, Physics·John A VargoDwight E Heron
Sep 25, 2018·International Journal of Particle Therapy·Jennifer MaNancy Y Lee
May 28, 2019·International Journal of Radiation Oncology, Biology, Physics·Amardeep S GrewalAlexander Lin

❮ Previous
Next ❯

Citations

Aug 6, 2021·Journal of Cancer Research and Clinical Oncology·Muhammad Shahid IqbalCharles Kelly
Aug 28, 2021·Current Oncology Reports·Ian W WinterGregory M M Videtic
Sep 7, 2021·Clinical & Experimental Metastasis·Francesco CucciaFilippo Alongi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved